Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

Lazo, 2008, The epidemiology of nonalcoholic fatty liver disease: a global perspective, Semin Liver Dis, 28, 339, 10.1055/s-0028-1091978 Day, 2002, Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?, Gut, 50, 585, 10.1136/gut.50.5.585 Hamaguchi, 2005, The metabolic syndrome as a predictor of nonalcoholic fatty liver disease, Ann Intern Med, 143, 722, 10.7326/0003-4819-143-10-200511150-00009 Matteoni, 1999, A non-alcoholic fatty liver disease: a spectrum of clinical and pathologic severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8 Day, 2002, Non-alcoholic steatohepatitis: definitions and pathogenesis, J Gastroenterol Hepatol, 17, 377, 10.1046/j.1440-1746.17.s3.31.x Harrison, 2003, The natural history of nonalcoholic fatty liver disease: a clinical histopathological study, Am J Gastroenterol, 98, 2042, 10.1111/j.1572-0241.2003.07659.x Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 18, 1221, 10.1056/NEJMra011775 Cadranel, 2002, Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future, Gastroenterol Clin Biol, 26, 823 Ratziu, 2005, Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 128, 1898, 10.1053/j.gastro.2005.03.084 Sandrin, 2002, Shear elasticity probe for soft tissues with 1-D transient elastography, IEEE Trans Ultrason Ferroelectr Freq Control, 49, 436, 10.1109/58.996561 Yoneda, 2007, Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD), Gut, 56, 1330, 10.1136/gut.2007.126417 Yoneda, 2008, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD), Dig Liver Dis, 40, 371, 10.1016/j.dld.2007.10.019 Kwok, 2014, Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease—the role of transient elastography and plasma cytokeratin-18 fragments, Aliment Pharmacol Ther, 39, 254, 10.1111/apt.12569 Sasso, 2010, Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes, Ultrasound Med Biol, 36, 1825, 10.1016/j.ultrasmedbio.2010.07.005 Alisi, 2009, Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease, Hepatology, 50, 2048, 10.1002/hep.23345 Chan, 2014, Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease, J Gastroenterol Hepatol, 29, 1470, 10.1111/jgh.12557 de Lédinghen, 2014, Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations, J Hepatol, 60, 1026, 10.1016/j.jhep.2013.12.018 Foucher, 2006, Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations, Eur J Gastroenterol Hepatol, 18, 411, 10.1097/00042737-200604000-00015 Carrión, 2008, MR elastography to assess liver fibrosis, Radiology, 247, 591, 10.1148/radiol.2472071844 Talwalkar, 2008, Elastography for detecting hepatic fibrosis: options and considerations, Gastroenterology, 135, 299, 10.1053/j.gastro.2008.05.038 Talwalkar, 2008, Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications, Hepatology, 47, 332, 10.1002/hep.21972 Huwart, 2008, Magnetic resonance elastography for the noninvasive staging of liver fibrosis, Gastroenterology, 135, 32, 10.1053/j.gastro.2008.03.076 Yin, 2007, Assessment of hepatic fibrosis with magnetic resonance elastography, Clin Gastroenterol Hepatol, 5, 1207, 10.1016/j.cgh.2007.06.012 Muthupillai, 1995, Magnetic resonance elastography by direct visualization of propagating acoustic strain waves, Science, 269, 1854, 10.1126/science.7569924 Chen, 2011, Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography, Radiology, 259, 749, 10.1148/radiol.11101942 Kim, 2013, Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography, Radiology, 268, 411, 10.1148/radiol.13121193 Loomba, 2014, Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study, Hepatology, 60, 1920, 10.1002/hep.27362 Reeder, 2009, Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling, J Magn Reson Imaging, 29, 1332, 10.1002/jmri.21751 Permutt, 2012, Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease-MRI accurately quantifies hepatic steatosis in NAFLD, Aliment Pharmacol Ther, 36, 22, 10.1111/j.1365-2036.2012.05121.x Younossi, 2011, Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality, Hepatology, 53, 1874, 10.1002/hep.24268 Brunt, 2001, Nonalcoholic steatohepatitis: definition and pathology, Semin Liver Dis, 21, 3, 10.1055/s-2001-12925 Hui, 2003, Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C, Hepatology, 38, 420, 10.1053/jhep.2003.50320 Levenson, 1991, Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy, AJR Am J Roentgenol, 156, 307, 10.2214/ajr.156.2.1898804 Bernstein, 2004 Hussain, 2005, Hepatic fat fraction: MR imaging for quantitative measurement and display-early experience, Radiology, 237, 1048, 10.1148/radiol.2373041639 Sandrin, 2003, Transient elastography: a new noninvasive method for assessment of hepatic fibrosis, Ultrasound Med Biol, 29, 1705, 10.1016/j.ultrasmedbio.2003.07.001 Sumida, 2012, Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population, BMC Gastroenterol, 12, 2, 10.1186/1471-230X-12-2 Angulo, 2007, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD, Hepatology, 45, 846, 10.1002/hep.21496 Wai, 2003, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C, Hepatology, 38, 518, 10.1053/jhep.2003.50346 Harrison, 2008, Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease, Gut, 57, 1441, 10.1136/gut.2007.146019 DeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, 44, 837, 10.2307/2531595 Sanyal, 2002, Treatment of non-alcoholic fatty liver disease, J Gastroenterol Hepatol, 17, 385, 10.1046/j.1440-1746.17.s3.32.x Regev, 2002, Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection, Am J Gastroenterol, 97, 2614, 10.1111/j.1572-0241.2002.06038.x Bedossa, 2009, Liver biopsy: the best, not the gold standard, J Hepatol, 50, 1, 10.1016/j.jhep.2008.10.014 Sporea, 2013, Can transient elastography be a reliable method for assessing liver fibrosis in nonalcoholic steatohepatitis (NASH)?, Med Ultrason, 15, 106, 10.11152/mu.2013.2066.152.is1aj2 Castéra, 2010, Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations, Hepatology, 51, 828 de Lédinghen, 2010, Feasibility of liver transient elastography with FibroScan using a new probe for obese patients, Liver Int, 30, 1043, 10.1111/j.1478-3231.2010.02258.x Chang, 2008, Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index, Aliment Pharmacol Ther, 28, 51, 10.1111/j.1365-2036.2008.03711.x Wong, 2012, Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease, Am J Gastroenterol, 107, 1862, 10.1038/ajg.2012.331 Venkatesh, 2013, Magnetic resonance elastography of the liver: technique, analysis, and clinical applications, J Magn Reson Imaging, 37, 544, 10.1002/jmri.23731 Faria, 2009, MR imaging of liver fibrosis: current state of the art, Radiographics, 29, 1615, 10.1148/rg.296095512 Hines, 2010, Repeatability of magnetic resonance elastography for quantification of hepatic stiffness, J Magn Reson Imaging, 31, 725, 10.1002/jmri.22066 Vernon, 2011, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Aliment Pharmacol Ther, 34, 274, 10.1111/j.1365-2036.2011.04724.x Adams, 2007, Nonalcoholic fatty liver disease, Ann Epidemiol, 17, 863, 10.1016/j.annepidem.2007.05.013 Kim, 2006, Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging–correlation with histopathologic findings, Radiology, 240, 116, 10.1148/radiol.2393042218 Yin, 2013, Hepatic and splenic stiffness augmentation assessed with MR elastography in an in vivo porcine portal hypertension model, J Magn Reson Imaging, 38, 809, 10.1002/jmri.24049 Bureau, 2008, Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease, Aliment Pharmacol Ther, 27, 1261, 10.1111/j.1365-2036.2008.03701.x